Alemtuzumab induced thyrotoxicosis in a patient undergoing autologous haematopoietic stem cell transplant for multiple sclerosis

Abstract

Background and progress in research Autologous Haematopoietic Stem Cell Transplant (AHSCT), also known as bone marrow transplant, is an experimental form of treatment that aims to reset, or 'reboot' the immune system to prevent the autoimmune attack on the central nervous system.